Angiopoietin-1 might be a novel therapeutic strategy for injured pulmonary capillaries in the developing lung
Angiopoietin-1 might be a novel therapeutic strategy for injured pulmonary capillaries in the developing lung
批准号:
16K10111
负责人:
Nakanishi Hidehiko
金额:
$2.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2016
资助国家:
日本
项目状态:
已结题
起止时间:
2016-04-01 至 2020-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ultra-structural characterization of pulmonary vascular disease in bronchopulmonary dysplasia ~Angiopoietin-1 might improve injured pulmonary microcirculation in the developing lung~
支气管肺发育不良中肺血管疾病的超微结构特征 ~Angiopoietin-1 可能会改善发育中肺部受损的肺微循环 ~
DOI:
--
发表时间:
2016
期刊:
影响因子:
--
作者:
[4.Nakanishi H. Morikawa S, Kitahara S, Yoshii A, Uchiyama A, Kusuda S, Ezaki T, Hidehiko Nakanishi]
通讯作者:
Hidehiko Nakanishi
DOI:
10.1007/s00795-018-0182-2
发表时间:
2018-01
期刊:
Medical Molecular Morphology
影响因子:
1.8
作者:
[H. Nakanishi;S. Morikawa;Shuji Kitahara;Asuka Yoshii;A. Uchiyama;S. Kusuda;T. Ezaki]
通讯作者:
H. Nakanishi;S. Morikawa;Shuji Kitahara;Asuka Yoshii;A. Uchiyama;S. Kusuda;T. Ezaki
Morphological characterization of the mechanism for pulmonary micovascular disease in bronchopulmonary dysplasia caused by hyperoxia in newborn mice
-
批准号:24591613
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2012
-
负责人:Nakanishi Hidehiko
-
依托单位:
海外基金